Name (Synonyms) | Correlation | |
---|---|---|
drug315 | Chlorpromazine Injection Wiki | 1.00 |
drug1657 | sodium chloride 0.9% Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D020141 | Hemostatic Disorders NIH | 0.41 |
D001778 | Blood Coagulation Disorders NIH | 0.41 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
To determine whether the coagulopathy associated with COVID-19 infection is driven by overactivation of the renin angiotensin system (RAS)
Description: Mean change from baseline D-dimer at 7 days following administration of TRV027 or placebo.
Measure: Coagulopathy associated with COVID-19 Time: Day 3, Day 5 and Day 7Description: Absolute D-Dimer - (Fibrin Equivalent units)
Measure: Markers of dysregulation of coagulation system Time: Assessed at 3,5 and 7 days during admissionDescription: platelet count (E9 /L)
Measure: Markers of dysregulation of coagulation system Time: Assessed at 3,5 and 7 days during admissionDescription: aPTT (Activated Partial Thromboplastin time) - seconds
Measure: Markers of dysregulation of coagulation system Time: Assessed at 3,5 and 7 days during admissionDescription: INR - (calculated as a ratio from aPTT)
Measure: Markers of dysregulation of coagulation system Time: Assessed at 3,5 and 7 days during admissionDescription: fibrinogen (g/L)
Measure: Markers of dysregulation of coagulation system Time: Assessed at 3,5 and 7 days during admissionDescription: Plasma Renin Mass and activity (ng/ml/h)
Measure: Markers of dysregulation of RAS Time: Assessed at 3,5 and 7 days during admission.Description: bilirubin (umol/L)
Measure: Markers of Haemolysis/inflammation Time: Assessed at 3,5 and 7 days during admission.Description: LDH u/L
Measure: Markers of Haemolysis/Inflammation Time: Assessed at 3,5 and 7 days during admission.Description: Haptoglobin g/L
Measure: Markers of Haemolysis/inflammation Time: Assessed at 3,5 and 7 days during admission.Description: Creatinine (umol/L)
Measure: Markers of organ dysregulation - kidney Time: Assessed at 3,5 and 7 days during admission.Description: BNP (B-type natriuetic Peptide) ng/L
Measure: Markers of dysregulation of cardiovascular system Time: Assessed at 3,5 and 7 days during admission.Description: Troponin ng/L
Measure: Markers of dysregulation of cardiovascular system Time: Assessed at 3,5 and 7 days during admission.